[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339129-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339129-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dynamics-ofthe-tcr-repertoires-during-the-dedierentiation-process-and-pilot-implications-for-immunotherapy-of-thyroid-cancer","Dynamics ofThe 􀀂􀀂tcr Repertoires During The Dediﬀerentiation Process and Pilot Implications for Immunotherapy of Thyroid Cancer","","T cells are evolutionarily conserved lymphocytes whose antitumor effects can operate independently of tumor mutation burden and conventional HLA recognition. However, the dynamic remodeling of the T cell receptor (TCR) repertoire across thyroid cancer progression and treatment is incompletely defined. This study characterizes TCR repertoire changes across divergent differentiation states, links differentiation status to repertoire diversity, identifies enriched highly expanded clones in дедиффerentiated patients, and evaluates longitudinal therapy-associated V2neg subset emergence with potential favorable outcomes, validated by single-cell analyses in patients and a murine model.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dynamics-ofthe-tcr-repertoires-during-the-dedierentiation-process-and-pilot-implications-for-immunotherapy-of-thyroid-cancer/339129/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dynamics-ofthe-tcr-repertoires-during-the-dedierentiation-process-and-pilot-implications-for-immunotherapy-of-thyroid-cancer/339129.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does the study connect thyroid cancer differentiation states to TCR repertoire features?","Question",{"text":63,"@type":64},"It reports a significant correlation between differentiation states and TCR repertoire diversity, with highly expanded clones enriched in the T cell compartment of дедиффerentiated patients.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the main observation from longitudinal analysis of T cell responses to therapies?",{"text":68,"@type":64},"Longitudinal investigation suggests that the emergence and expansion of the V2neg subset may be associated with favorable clinical outcomes after post-radiotherapeutic immunotherapy.",{"name":70,"@type":61,"acceptedAnswer":71},"How were the findings validated beyond bulk-level observations?",{"text":72,"@type":64},"The study further validates the results at single-cell resolution in both advanced thyroid cancer patients and a murine model.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339129,1790463728,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE  \n[www.advancedscience.com](www.advancedscience.com)  \nDynamics ofThe 􀀂􀀂tcr Repertoires During The Dediﬀerentiation Process and Pilot Implications for Immunotherapy of Thyroid Cancer  \nQing Hao, Ruicen Li, Hancong Li, Shu Rui, Liting You, Lingyun Zhang, Yue Zhao, Peiheng Li, Yuanmin Li, Xinagyu Kong, Haining Chen, Xiuhe Zou, Feng Liu, Xiaofei Wang, Juan Zhou, Weihan Zhang, Libing Huang, Yang Shu, JiaYe Liu, Ronghao Sun, Chao Li, Jingqiang Zhu, Yong Jiang, Tao Wei, Kun Qian, Bing Bai, Yiguo Hu, Yong Peng,  \nLunzhi Dai, Carlos Caulin, Heng Xu, Zhihui Li,* Jihwan Park,* Han Luo,* and Binwu Ying  \n􀀃􀀂 T cells are evolutionarily conserved T lymphocytes that manifest unique antitumor eﬃcacy independent of tumor mutation burden (TMB) and conventional human leukocyte antigen (HLA) recognition. However, the dynamic changes in their T cell receptor (TCR) repertoire during cancer progression and treatment courses remain unclear. Here, a comprehensive characterization of 􀀃􀀂TCR repertoires are performed in thyroid cancers with divergent diﬀerentiation states through cross-sectional studies. The ﬁndings revealed a signiﬁcant correlation between the diﬀerentiation states and TCR repertoire diversity. Notably, highly expanded clones are prominently enriched in 􀀃􀀂 T cell compartment of dediﬀerentiated patients. Moreover, by longitudinal investigations ofthe 􀀃􀀂 T cell response to various antitumor therapies, it is found that the emergence and expansion of the V􀀂2neg subset may be potentially associated with favorable clinical outcomes after  \npost-radiotherapeutic immunotherapy. These ﬁndings are further validated at single-cell resolution in both advanced thyroid cancer patients and a murine model, underlining the importance of further investigations into the role of 􀀃􀀂TCR in cancer immunity and therapeutic strategies.  \n1. Introduction  \nThyroid cancer is the most common endocrine malignancy, with incidence rates continuing to increase in the past few decades. [1] Follicular cell-derived thyroid cancer mainly includes various histotypes ranging from well diﬀerentiated papillary thyroid cancer (PTC) to poorly diﬀerentiated (PDTC) and undiﬀerentiated/anaplastic (ATC) thyroid cancer. The patient outcome becomes bleaker asdediﬀerentiation progresses, with median survival shifting from 10 to 0.5 years. Furthermore, akin to other malignancies, the metastasis of thyroid cancer is often correlated with its progression state. [2] Thus, widely invasive PTC (wiPTC) featuring distant metastasis is clearly distinct from typical PTC in terms of diﬀerentiation state. Our previous investigations examined the genetic variations, tumor mutation  \nQ. Hao, L. You, J. Zhou, H. Xu, H. Luo, B. Ying Department of Laboratory Medicine  \nWest China Hospital, Sichuan University Chengdu, Sichuan 610041, China  \nE-mail: [luohan-hx@scu.edu.cn](luohan-hx@scu.edu.cn)  \nQ. Hao, Y. Hu, Y. Peng, L. Dai, H. Xu  \nState Key Laboratory of Biotherapy and Cancer Center, West China Hospital Sichuan University and Collaborative Innovation Center  \nChengdu, Sichuan 610041, China  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202306364](https://doi.org/10.1002/advs.202306364)[ ](https://doi.org/10.1002/advs.202306364)© 2024 The Authors. Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nDOI: 10.1002/advs.202306364  \nR. Li  \nHealth Promotion Center  \nWest China Hospital, Sichuan University Chengdu, Sichuan 610041, China  \nH. Li, S. Rui, Y. Zhao, P. Li, Y. Li, X. Kong, X. Zou, F. Liu, X. Wang, J. Liu,  \nJ. Zhu, T. Wei, Y. Hu, Z. Li, H. Luo  \nDivision of Thyroid Surgery, West China Hospital Sichuan University  \nChengdu, Sichuan 610041, China  \nE-mail: [rockoliver@vip.sina.com](rockoliver@vip.sina.com)  \nH. ","cbCailSuRWnpJRLn","https://ap.wps.com/l/cbCailSuRWnpJRLn","pdf",5954052,15,"English","# Introduction\n## Thyroid cancer differentiation and clinical outcome\n## TCR repertoire dynamics and research gap\n# Study aims and approach\n## Cross-sectional repertoire characterization\n## Longitudinal responses to antitumor therapies\n## Single-cell validation in patients and a murine model","[{\"question\":\"How does the study connect thyroid cancer differentiation states to TCR repertoire features?\",\"answer\":\"It reports a significant correlation between differentiation states and TCR repertoire diversity, with highly expanded clones enriched in the T cell compartment of дедиффerentiated patients.\"},{\"question\":\"What is the main observation from longitudinal analysis of T cell responses to therapies?\",\"answer\":\"Longitudinal investigation suggests that the emergence and expansion of the V2neg subset may be associated with favorable clinical outcomes after post-radiotherapeutic immunotherapy.\"},{\"question\":\"How were the findings validated beyond bulk-level observations?\",\"answer\":\"The study further validates the results at single-cell resolution in both advanced thyroid cancer patients and a murine model.\"}]","Dynamics ofThe 􀀂􀀂tcr Repertoires During The Dediﬀerentiation Process and Pilot Implications for Immunotherapy of Thyroid Cancer | PDF",1790028108,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f8d1ab8e835294ea1f8fb98459467e5.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2792e427798d82bed61fedd9da35a3c.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0cc274ee632d6b4671b2d04d943a97d.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26d25bc66d5265eb71a644293b7f9143.webp",980,1287]